Trials / Completed
CompletedNCT02019355
Actinic Keratosis Study
The Role of Calcipotriol in Treatment of Pre-cancerous Skin Lesions
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to determine the effectiveness of a new combination therapy for actinic keratosis. This study investigates a new indication for an FDA-approved topical medication, calcipotriol, for treatment of actinic keratosis, including how well it works and how safe it is when used in combination with the standard of care medication (5-fluorouracil) for the skin condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5-fluorouracil 5% cream | |
| DRUG | Calcipotriol 0.005% ointment | |
| DRUG | Vaseline |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2013-12-24
- Last updated
- 2016-05-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02019355. Inclusion in this directory is not an endorsement.